Equity Overview
Price & Market Data
Price: $1.45
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $6,637,882
Daily Volume: 0
Performance Metrics
1 Week: -15.20%
1 Month: -21.62%
3 Months: -40.57%
6 Months: -80.14%
1 Year: -88.56%
YTD: -66.44%
Company Details
Employees: 26
Sector: Health technology
Industry: Biotechnology
Country:
Details
Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.